This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1988 May;9(5):209-11.

doi: 10.1086/645836.

Teicoplanin--a new agent for gram-positive bacterial infections

M Eggleston¹, J Ofosu

Affiliations

PMID: 2967322
DOI: 10.1086/645836

Review

Teicoplanin--a new agent for gram-positive bacterial infections

M Eggleston et al. Infect Control Hosp Epidemiol. 1988 May.

. 1988 May;9(5):209-11.

doi: 10.1086/645836.

Authors

M Eggleston¹, J Ofosu

Affiliation

¹ Howard University, College of Pharmacy and Pharmacal Sciences, Washington, DC.

PMID: 2967322
DOI: 10.1086/645836

No abstract available

PubMed Disclaimer

Similar articles

Clinical efficacy and safety of teicoplanin in the treatment of gram-positive infections.
Kempf P, Pompetzki H, Oppermann A, Wittenberger R, Siebert J, Fell JJ, Dieterich HA. Kempf P, et al. Infection. 1989 May-Jun;17(3):177-81. doi: 10.1007/BF01644026. Infection. 1989. PMID: 2525529 Clinical Trial.
Infections due to gram-positive organisms in children: possible role for teicoplanin.
Dagan R, Einhorn M, Howard CB, Williams AH. Dagan R, et al. J Antimicrob Chemother. 1991 Apr;27 Suppl B:37-41. doi: 10.1093/jac/27.suppl_b.37. J Antimicrob Chemother. 1991. PMID: 1829075 Review.
Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
Campoli-Richards DM, Brogden RN, Faulds D. Campoli-Richards DM, et al. Drugs. 1990 Sep;40(3):449-86. doi: 10.2165/00003495-199040030-00007. Drugs. 1990. PMID: 2146108 Review.
Teicoplanin in the treatment of infection caused by gram-positive organisms.
Williams AH, Grüneberg RN, Webster A, Ridgway GL. Williams AH, et al. J Hosp Infect. 1986 Mar;7 Suppl A:101-3. doi: 10.1016/0195-6701(86)90014-9. J Hosp Infect. 1986. PMID: 2871091
Dalbavancin: an investigational glycopeptide.
Guay DR. Guay DR. Expert Rev Anti Infect Ther. 2004 Dec;2(6):845-52. doi: 10.1586/14789072.2.6.845. Expert Rev Anti Infect Ther. 2004. PMID: 15566329 Review.

See all similar articles

Cited by

Effects of teicoplanin on cell number of cultured cell lines.
Kashkolinejad-Koohi T, Saadat I, Saadat M. Kashkolinejad-Koohi T, et al. Interdiscip Toxicol. 2015 Mar;8(1):22-4. doi: 10.1515/intox-2015-0004. Interdiscip Toxicol. 2015. PMID: 27486356 Free PMC article.
Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.
Gilbert DN, Wood CA, Kimbrough RC. Gilbert DN, et al. Antimicrob Agents Chemother. 1991 Jan;35(1):79-87. doi: 10.1128/AAC.35.1.79. Antimicrob Agents Chemother. 1991. PMID: 1826594 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information